ID   ROS_HUMAN               Reviewed;        2347 AA.
AC   P08922; Q15368; Q5TDB5;
DT   01-NOV-1988, integrated into UniProtKB/Swiss-Prot.
DT   20-FEB-2007, sequence version 3.
DT   02-NOV-2010, entry version 116.
DE   RecName: Full=Proto-oncogene tyrosine-protein kinase ROS;
DE            EC=2.7.10.1;
DE   AltName: Full=Proto-oncogene c-Ros-1;
DE   Flags: Precursor;
GN   Name=ROS1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANTS ASN-2213; GLN-2228 AND
RP   CYS-2229.
RX   MEDLINE=90280463; PubMed=2352949; DOI=10.1073/pnas.87.12.4799;
RA   Birchmeier C., O'Neill K., Riggs M., Wigler M.;
RT   "Characterization of ROS1 cDNA from a human glioblastoma cell line.";
RL   Proc. Natl. Acad. Sci. U.S.A. 87:4799-4803(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   MEDLINE=22935763; PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1790-2260.
RX   MEDLINE=87064611; PubMed=3023956;
RA   Matsushime H., Wang L.-H., Shibuya M.;
RT   "Human c-ros-1 gene homologous to the v-ros sequence of UR2 sarcoma
RT   virus encodes for a transmembrane receptorlike molecule.";
RL   Mol. Cell. Biol. 6:3000-3004(1986).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1854-2347.
RX   MEDLINE=87064625; PubMed=3785223;
RA   Birchmeier C., Birnbaum D., Waitches G., Fasano O., Wigler M.;
RT   "Characterization of an activated human ros gene.";
RL   Mol. Cell. Biol. 6:3109-3116(1986).
RN   [5]
RP   TISSUE SPECIFICITY.
RX   PubMed=8143271; DOI=10.1016/0165-4608(94)90128-7;
RA   Watkins D., Dion F., Poisson M., Delattre J.Y., Rouleau G.A.;
RT   "Analysis of oncogene expression in primary human gliomas: evidence
RT   for increased expression of the ros oncogene.";
RL   Cancer Genet. Cytogenet. 72:130-136(1994).
RN   [6]
RP   DISEASE, AND CHROMOSOMAL TRANSLOCATION WITH GOPC.
RX   PubMed=12661006; DOI=10.1002/gcc.10207;
RA   Charest A., Lane K., McMahon K., Park J., Preisinger E., Conroy H.,
RA   Housman D.;
RT   "Fusion of FIG to the receptor tyrosine kinase ROS in a glioblastoma
RT   with an interstitial del(6)(q21q21).";
RL   Genes Chromosomes Cancer 37:58-71(2003).
RN   [7]
RP   VARIANTS [LARGE SCALE ANALYSIS] SER-13; VAL-126; PRO-145; GLN-167;
RP   SER-224; CYS-338; PRO-370; HIS-419; MET-537; PHE-653; HIS-865;
RP   LEU-1109; PHE-1239; SER-1353; ARG-1370; GLY-1506; HIS-1776; LYS-1902;
RP   ASN-1999; ARG-2003; SER-2138; ASN-2203; GLU-2213; ASN-2213; GLN-2228;
RP   CYS-2229 AND LYS-2240.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: This is probably a cell growth or differentiation factor
CC       receptor with a tyrosine-protein kinase activity.
CC   -!- CATALYTIC ACTIVITY: ATP + a [protein]-L-tyrosine = ADP + a
CC       [protein]-L-tyrosine phosphate.
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- TISSUE SPECIFICITY: Expressed in brain. Expression is increased in
CC       primary gliomas.
CC   -!- DISEASE: Note=A chromosomal aberration involving ROS1 is found in
CC       a glioblastoma multiforme sample. An intra-chromosomal deletion
CC       del(6)(q21q21) is responsible for the formation of GOPC-ROS1
CC       chimeric protein which has a constitutive receptor tyrosine kinase
CC       activity.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. Insulin receptor subfamily.
CC   -!- SIMILARITY: Contains 9 fibronectin type-III domains.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M34353; AAA60278.1; -; mRNA.
DR   EMBL; Z98880; CAI42374.1; -; Genomic_DNA.
DR   EMBL; AL132671; CAI42374.1; JOINED; Genomic_DNA.
DR   EMBL; AL132671; CAI23378.1; -; Genomic_DNA.
DR   EMBL; Z98880; CAI23378.1; JOINED; Genomic_DNA.
DR   EMBL; M13599; AAA60277.1; -; Genomic_DNA.
DR   EMBL; M13368; AAA60277.1; JOINED; Genomic_DNA.
DR   EMBL; M13591; AAA60277.1; JOINED; Genomic_DNA.
DR   EMBL; M13592; AAA60277.1; JOINED; Genomic_DNA.
DR   EMBL; M13593; AAA60277.1; JOINED; Genomic_DNA.
DR   EMBL; M13594; AAA60277.1; JOINED; Genomic_DNA.
DR   EMBL; M13595; AAA60277.1; JOINED; Genomic_DNA.
DR   EMBL; M13596; AAA60277.1; JOINED; Genomic_DNA.
DR   EMBL; M13597; AAA60277.1; JOINED; Genomic_DNA.
DR   EMBL; M13598; AAA60277.1; JOINED; Genomic_DNA.
DR   EMBL; M13880; AAA36580.1; -; mRNA.
DR   IPI; IPI00288965; -.
DR   PIR; A35512; TVHURS.
DR   RefSeq; NP_002935.2; -.
DR   UniGene; Hs.1041; -.
DR   ProteinModelPortal; P08922; -.
DR   MINT; MINT-2800684; -.
DR   STRING; P08922; -.
DR   PhosphoSite; P08922; -.
DR   PRIDE; P08922; -.
DR   Ensembl; ENST00000368508; ENSP00000357494; ENSG00000047936.
DR   GeneID; 6098; -.
DR   KEGG; hsa:6098; -.
DR   UCSC; uc003pxp.1; human.
DR   CTD; 6098; -.
DR   GeneCards; GC06M117609; -.
DR   HGNC; HGNC:10261; ROS1.
DR   MIM; 165020; gene.
DR   PharmGKB; PA33809; -.
DR   eggNOG; prNOG09325; -.
DR   HOGENOM; HBG279743; -.
DR   HOVERGEN; HBG058631; -.
DR   InParanoid; P08922; -.
DR   OMA; FQFYSTL; -.
DR   PhylomeDB; P08922; -.
DR   BRENDA; 2.7.10.1; 247.
DR   NextBio; 23723; -.
DR   ArrayExpress; P08922; -.
DR   Bgee; P08922; -.
DR   CleanEx; HS_ROS1; -.
DR   Genevestigator; P08922; -.
DR   GermOnline; ENSG00000047936; Homo sapiens.
DR   GO; GO:0005624; C:membrane fraction; TAS:ProtInc.
DR   GO; GO:0005890; C:sodium:potassium-exchanging ATPase complex; TAS:ProtInc.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005515; F:protein binding; IEA:InterPro.
DR   GO; GO:0004714; F:transmembrane receptor protein tyrosine kin...; IEA:EC.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IEA:InterPro.
DR   GO; GO:0007169; P:transmembrane receptor protein tyrosine kin...; IEA:InterPro.
DR   InterPro; IPR011042; 6-blade_b-propeller_TolB-like.
DR   InterPro; IPR008957; Fibronectin_III_dom.
DR   InterPro; IPR003961; FN_III.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000033; LDLR_classB_rpt.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001245; Ser-Thr/Tyr-Pkinase.
DR   InterPro; IPR020738; Tyr_kinase_rcpt_ROS/Sevenless.
DR   InterPro; IPR020635; Tyr_Pkinase_cat_dom.
DR   InterPro; IPR020685; Tyr_prot_kinase.
DR   InterPro; IPR008266; Tyr_prot_kinase_AS.
DR   InterPro; IPR002011; Tyr_prot_kinase_rcpt_2_CS.
DR   Gene3D; G3DSA:2.120.10.30; 6-blade_b-propeller_TolB-like; 3.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 8.
DR   PANTHER; PTHR23256:SF249; Tyr_kinase_rcpt_ROS/Sevenless; 1.
DR   PANTHER; PTHR23256; Tyr_prot_kinase; 1.
DR   Pfam; PF00041; fn3; 4.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00060; FN3; 9.
DR   SMART; SM00135; LY; 4.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF49265; FN_III-like; 8.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS50853; FN3; 9.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
DR   PROSITE; PS00239; RECEPTOR_TYR_KIN_II; 1.
PE   2: Evidence at transcript level;
KW   ATP-binding; Chromosomal rearrangement; Complete proteome;
KW   Glycoprotein; Kinase; Membrane; Nucleotide-binding; Phosphoprotein;
KW   Polymorphism; Proto-oncogene; Receptor; Repeat; Signal; Transferase;
KW   Transmembrane; Transmembrane helix; Tyrosine-protein kinase.
FT   SIGNAL        1     27       Potential.
FT   CHAIN        28   2347       Proto-oncogene tyrosine-protein kinase
FT                                ROS.
FT                                /FTId=PRO_0000016722.
FT   TOPO_DOM     28   1859       Extracellular (Potential).
FT   TRANSMEM   1860   1882       Helical; (Potential).
FT   TOPO_DOM   1883   2347       Cytoplasmic (Potential).
FT   DOMAIN       98    188       Fibronectin type-III 1.
FT   DOMAIN      194    281       Fibronectin type-III 2.
FT   DOMAIN      558    668       Fibronectin type-III 3.
FT   DOMAIN      944   1036       Fibronectin type-III 4.
FT   DOMAIN     1041   1147       Fibronectin type-III 5.
FT   DOMAIN     1450   1548       Fibronectin type-III 6.
FT   DOMAIN     1558   1653       Fibronectin type-III 7.
FT   DOMAIN     1655   1748       Fibronectin type-III 8.
FT   DOMAIN     1749   1851       Fibronectin type-III 9.
FT   DOMAIN     1945   2222       Protein kinase.
FT   NP_BIND    1951   1959       ATP (By similarity).
FT   ACT_SITE   2079   2079       Proton acceptor (By similarity).
FT   BINDING    1980   1980       ATP (By similarity).
FT   SITE       1880   1881       Breakpoint for translocation to form
FT                                GOPC-ROS1 fusion protein.
FT   MOD_RES    2114   2114       Phosphotyrosine; by autocatalysis (By
FT                                similarity).
FT   CARBOHYD     52     52       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    114    114       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    123    123       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    324    324       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    352    352       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    396    396       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    471    471       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    607    607       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    628    628       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    706    706       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    714    714       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    732    732       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    939    939       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    961    961       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD   1015   1015       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD   1087   1087       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD   1090   1090       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD   1095   1095       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD   1211   1211       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD   1272   1272       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD   1330   1330       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD   1458   1458       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD   1461   1461       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD   1474   1474       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD   1499   1499       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD   1565   1565       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD   1669   1669       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD   1715   1715       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD   1738   1738       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD   1808   1808       N-linked (GlcNAc...) (Potential).
FT   VARIANT      13     13       N -> S (in dbSNP:rs45606237).
FT                                /FTId=VAR_041442.
FT   VARIANT     126    126       G -> V (in dbSNP:rs34245787).
FT                                /FTId=VAR_041443.
FT   VARIANT     145    145       T -> P (in dbSNP:rs1998206).
FT                                /FTId=VAR_030648.
FT   VARIANT     167    167       R -> Q (in dbSNP:rs2243380).
FT                                /FTId=VAR_030649.
FT   VARIANT     224    224       P -> S (in dbSNP:rs55959124).
FT                                /FTId=VAR_041444.
FT   VARIANT     338    338       Y -> C (in dbSNP:rs55707658).
FT                                /FTId=VAR_041445.
FT   VARIANT     370    370       S -> P (in dbSNP:rs56274823).
FT                                /FTId=VAR_041446.
FT   VARIANT     419    419       Y -> H (in a gastric adenocarcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_041447.
FT   VARIANT     537    537       I -> M (in dbSNP:rs28639589).
FT                                /FTId=VAR_041448.
FT   VARIANT     653    653       S -> F (in dbSNP:rs34203286).
FT                                /FTId=VAR_041449.
FT   VARIANT     790    790       N -> S (in dbSNP:rs34582164).
FT                                /FTId=VAR_049712.
FT   VARIANT     865    865       Q -> H (in a lung large cell carcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_041450.
FT   VARIANT    1109   1109       S -> L (in dbSNP:rs2229079).
FT                                /FTId=VAR_030650.
FT   VARIANT    1239   1239       Y -> F (in dbSNP:rs56192249).
FT                                /FTId=VAR_041451.
FT   VARIANT    1353   1353       Y -> S (in dbSNP:rs35269727).
FT                                /FTId=VAR_041452.
FT   VARIANT    1370   1370       C -> R (in dbSNP:rs36106063).
FT                                /FTId=VAR_041453.
FT   VARIANT    1439   1439       F -> S (in dbSNP:rs17079086).
FT                                /FTId=VAR_030651.
FT   VARIANT    1506   1506       R -> G (in dbSNP:rs35841892).
FT                                /FTId=VAR_041454.
FT   VARIANT    1776   1776       D -> H (in dbSNP:rs12664076).
FT                                /FTId=VAR_030652.
FT   VARIANT    1902   1902       E -> K (in dbSNP:rs9489124).
FT                                /FTId=VAR_030653.
FT   VARIANT    1999   1999       H -> N (in dbSNP:rs45569132).
FT                                /FTId=VAR_041455.
FT   VARIANT    2003   2003       K -> R (in a colorectal adenocarcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_041456.
FT   VARIANT    2039   2039       R -> H (in dbSNP:rs3752566).
FT                                /FTId=VAR_030654.
FT   VARIANT    2138   2138       F -> S (in a gastric adenocarcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_041457.
FT   VARIANT    2203   2203       D -> N.
FT                                /FTId=VAR_041458.
FT   VARIANT    2213   2213       D -> E.
FT                                /FTId=VAR_041459.
FT   VARIANT    2213   2213       D -> N (in dbSNP:rs529038).
FT                                /FTId=VAR_030655.
FT   VARIANT    2228   2228       K -> Q (in dbSNP:rs529156).
FT                                /FTId=VAR_041460.
FT   VARIANT    2229   2229       S -> C (in dbSNP:rs619203).
FT                                /FTId=VAR_030656.
FT   VARIANT    2240   2240       N -> K (in dbSNP:rs210968).
FT                                /FTId=VAR_030657.
FT   VARIANT    2328   2328       K -> R (in dbSNP:rs35932630).
FT                                /FTId=VAR_049713.
FT   CONFLICT   2246   2260       EDGDVICLNSDDIMP -> KFDSSEFSSFRCTVN (in
FT                                Ref. 3; AAA60277).
FT   CONFLICT   2262   2262       A -> V (in Ref. 1; AAA60278).
SQ   SEQUENCE   2347 AA;  263915 MW;  98902B9A59ACB8F5 CRC64;
     MKNIYCLIPK LVNFATLGCL WISVVQCTVL NSCLKSCVTN LGQQLDLGTP HNLSEPCIQG
     CHFWNSVDQK NCALKCRESC EVGCSSAEGA YEEEVLENAD LPTAPFASSI GSHNMTLRWK
     SANFSGVKYI IQWKYAQLLG SWTYTKTVSR PSYVVKPLHP FTEYIFRVVW IFTAQLQLYS
     PPSPSYRTHP HGVPETAPLI RNIESSSPDT VEVSWDPPQF PGGPILGYNL RLISKNQKLD
     AGTQRTSFQF YSTLPNTIYR FSIAAVNEVG EGPEAESSIT TSSSAVQQEE QWLFLSRKTS
     LRKRSLKHLV DEAHCLRLDA IYHNITGISV DVHQQIVYFS EGTLIWAKKA ANMSDVSDLR
     IFYRGSGLIS SISIDWLYQR MYFIMDELVC VCDLENCSNI EEITPPSISA PQKIVADSYN
     GYVFYLLRDG IYRADLPVPS GRCAEAVRIV ESCTLKDFAI KPQAKRIIYF NDTAQVFMST
     FLDGSASHLI LPRIPFADVK SFACENNDFL VTDGKVIFQQ DALSFNEFIV GCDLSHIEEF
     GFGNLVIFGS SSQLHPLPGR PQELSVLFGS HQALVQWKPP ALAIGANVIL ISDIIELFEL
     GPSAWQNWTY EVKVSTQDPP EVTHIFLNIS GTMLNVPELQ SAMKYKVSVR ASSPKRPGPW
     SEPSVGTTLV PASEPPFIMA VKEDGLWSKP LNSFGPGEFL SSDIGNVSDM DWYNNSLYYS
     DTKGDVFVWL LNGTDISENY HLPSIAGAGA LAFEWLGHFL YWAGKTYVIQ RQSVLTGHTD
     IVTHVKLLVN DMVVDSVGGY LYWTTLYSVE STRLNGESSL VLQTQPWFSG KKVIALTLDL
     SDGLLYWLVQ DSQCIHLYTA VLRGQSTGDT TITEFAAWST SEISQNALMY YSGRLFWING
     FRIITTQEIG QKTSVSVLEP ARFNQFTIIQ TSLKPLPGNF SFTPKVIPDS VQESSFRIEG
     NASSFQILWN GPPAVDWGVV FYSVEFSAHS KFLASEQHSL PVFTVEGLEP YALFNLSVTP
     YTYWGKGPKT SLSLRAPETV PSAPENPRIF ILPSGKCCNK NEVVVEFRWN KPKHENGVLT
     KFEIFYNISN QSITNKTCED WIAVNVTPSV MSFQLEGMSP RCFIAFQVRA FTSKGPGPYA
     DVVKSTTSEI NPFPHLITLL GNKIVFLDMD QNQVVWTFSA ERVISAVCYT ADNEMGYYAE
     GDSLFLLHLH NRSSSELFQD SLVFDITVIT IDWISRHLYF ALKESQNGMQ VFDVDLEHKV
     KYPREVKIHN RNSTIISFSV YPLLSRLYWT EVSNFGYQMF YYSIISHTLH RILQPTATNQ
     QNKRNQCSCN VTEFELSGAM AIDTSNLEKP LIYFAKAQEI WAMDLEGCQC WRVITVPAML
     AGKTLVSLTV DGDLIYWIIT AKDSTQIYQA KKGNGAIVSQ VKALRSRHIL AYSSVMQPFP
     DKAFLSLASD TVEPTILNAT NTSLTIRLPL AKTNLTWYGI TSPTPTYLVY YAEVNDRKNS
     SDLKYRILEF QDSIALIEDL QPFSTYMIQI AVKNYYSDPL EHLPPGKEIW GKTKNGVPEA
     VQLINTTVRS DTSLIISWRE SHKPNGPKES VRYQLAISHL ALIPETPLRQ SEFPNGRLTL
     LVTRLSGGNI YVLKVLACHS EEMWCTESHP VTVEMFNTPE KPYSLVPENT SLQFNWKAPL
     NVNLIRFWVE LQKWKYNEFY HVKTSCSQGP AYVCNITNLQ PYTSYNVRVV VVYKTGENST
     SLPESFKTKA GVPNKPGIPK LLEGSKNSIQ WEKAEDNGCR ITYYILEIRK STSNNLQNQN
     LRWKMTFNGS CSSVCTWKSK NLKGIFQFRV VAANNLGFGE YSGISENIIL VGDDFWIPET
     SFILTIIVGI FLVVTIPLTF VWHRRLKNQK SAKEGVTVLI NEDKELAELR GLAAGVGLAN
     ACYAIHTLPT QEEIENLPAF PREKLTLRLL LGSGAFGEVY EGTAVDILGV GSGEIKVAVK
     TLKKGSTDQE KIEFLKEAHL MSKFNHPNIL KQLGVCLLNE PQYIILELME GGDLLTYLRK
     ARMATFYGPL LTLVDLVDLC VDISKGCVYL ERMHFIHRDL AARNCLVSVK DYTSPRIVKI
     GDFGLARDIY KNDYYRKRGE GLLPVRWMAP ESLMDGIFTT QSDVWSFGIL IWEILTLGHQ
     PYPAHSNLDV LNYVQTGGRL EPPRNCPDDL WNLMTQCWAQ EPDQRPTFHR IQDQLQLFRN
     FFLNSIYKSR DEANNSGVIN ESFEGEDGDV ICLNSDDIMP VALMETKNRE GLNYMVLATE
     CGQGEEKSEG PLGSQESESC GLRKEEKEPH ADKDFCQEKQ VAYCPSGKPE GLNYACLTHS
     GYGDGSD
//
